Climb Bio, Inc. — Director's Dealing 2025

Jun 5, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Climb Bio, Inc. (CLYM)
CIK: 0001768446
Period of Report: 2025-06-04

Reporting Person: Cumbo Alexander (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-04	Stock Option (Right to Buy)	$1.29	A	40000	Acquired	2035-06-03	Common Stock (40000)	Direct

Footnotes

F1: The shares subject to the option will vest on the earlier of June 4, 2026 or the date immediately prior to the date of the next annual meeting of stockholders, subject to the reporting person's continued service through such date.